STAAR Surgical is trading 6.3% down today at $21.47 amid a broader risk-off move affecting growth and medical-technology names.
- There are no fresh company-specific headlines, earnings reports, or analyst actions today to account for the decline.
- The drop appears tied to wider weakness in the tech and growth sectors, even as the broader healthcare sector remains relatively firm.
- Recent coverage on the company remains positive, highlighting prior Q1 strength and several raised price targets rather than new fundamental negatives.